leer
leer
leer
DeutschEnglishImprint
navifuellAbout usleerTechnology PlatformleerProduct PipelineleerHow to PartnerleerInvestor RelationsleerNewsleerContactleer
linie
leer
leer
Strategy
Management
Supervisory Board
External Partners

 

bildmotiv1
Motivpunkte
leer
leer

To Novaliq, the continuous expansion of its product pipeline in collaboration with universities and other medical/biopharmaceutical companies is of great importance.

In pursuing this strategy, Novaliq has formed research and development cooperations with:

University of Cologne, with Prof. Claus Cursiefen and Dr. Philipp Steren in the field of ophthalmic drug delivery for the anterior segment of the eye

University of Malmö, with Johan Engblom, PhD, in the field of semifluorinated alkanes

University of Oxford, with Dr. Daniel Brandhorst, in the field of islet preservation

 

 

 
leer
leer © 2016 Novaliq GmbH Germany. All rights reserved.